 | • レポートコード：QFJ1-3786 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、アルツハイマー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノアミン酸化酵素、疼痛抑制剤（アセチルコリンエステラーゼ）、グルタメート阻害剤）、用途別市場規模（病院薬局、小売薬局、オンライン販売）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アルツハイマー病治療の市場動向 ・企業の競争状況、市場シェア ・アルツハイマー病治療の種類別市場規模と予測2016-2027（モノアミン酸化酵素、疼痛抑制剤（アセチルコリンエステラーゼ）、グルタメート阻害剤） ・アルツハイマー病治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン販売） ・アルツハイマー病治療の北米市場規模2016-2027（アメリカ、カナダ） ・アルツハイマー病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アルツハイマー病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アルツハイマー病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・アルツハイマー病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Eisai、Novartis、Teva Pharmaceutical Industries、Amgen、Pfizer、UCB、H. Lundbeck、F. Hoffmann-La Roche、Eli Lilly、Ono Pharmaceutical、Johnson & Johnson、Daiichi Sankyo、Merz Pharma） ・結論 |
Market Analysis and Insights: Global Alzheimer Disease Treatment Market
The global Alzheimer Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alzheimer Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alzheimer Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alzheimer Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alzheimer Disease Treatment market.
Global Alzheimer Disease Treatment Scope and Market Size
Alzheimer Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Monoamine Oxidase
Pain Inhibitor (acetylcholinesterase)
Glutamate Inhibitor
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Eisai
Novartis
Teva Pharmaceutical Industries
Amgen
Pfizer
UCB
H. Lundbeck
F. Hoffmann-La Roche
Eli Lilly
Ono Pharmaceutical
Johnson & Johnson
Daiichi Sankyo
Merz Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoamine Oxidase
1.2.3 Pain Inhibitor (acetylcholinesterase)
1.2.4 Glutamate Inhibitor
1.3 Market by Application
1.3.1 Global Alzheimer Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer Disease Treatment Market Perspective (2016-2027)
2.2 Alzheimer Disease Treatment Growth Trends by Regions
2.2.1 Alzheimer Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alzheimer Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Alzheimer Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Alzheimer Disease Treatment Industry Dynamic
2.3.1 Alzheimer Disease Treatment Market Trends
2.3.2 Alzheimer Disease Treatment Market Drivers
2.3.3 Alzheimer Disease Treatment Market Challenges
2.3.4 Alzheimer Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer Disease Treatment Players by Revenue
3.1.1 Global Top Alzheimer Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Alzheimer Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alzheimer Disease Treatment Revenue
3.4 Global Alzheimer Disease Treatment Market Concentration Ratio
3.4.1 Global Alzheimer Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer Disease Treatment Revenue in 2020
3.5 Alzheimer Disease Treatment Key Players Head office and Area Served
3.6 Key Players Alzheimer Disease Treatment Product Solution and Service
3.7 Date of Enter into Alzheimer Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer Disease Treatment Breakdown Data by Type
4.1 Global Alzheimer Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Alzheimer Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Alzheimer Disease Treatment Breakdown Data by Application
5.1 Global Alzheimer Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Alzheimer Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Alzheimer Disease Treatment Market Size (2016-2027)
6.2 North America Alzheimer Disease Treatment Market Size by Type
6.2.1 North America Alzheimer Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Alzheimer Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Alzheimer Disease Treatment Market Size by Type (2016-2027)
6.3 North America Alzheimer Disease Treatment Market Size by Application
6.3.1 North America Alzheimer Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Alzheimer Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Alzheimer Disease Treatment Market Size by Application (2016-2027)
6.4 North America Alzheimer Disease Treatment Market Size by Country
6.4.1 North America Alzheimer Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Alzheimer Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Alzheimer Disease Treatment Market Size (2016-2027)
7.2 Europe Alzheimer Disease Treatment Market Size by Type
7.2.1 Europe Alzheimer Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Alzheimer Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Alzheimer Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Alzheimer Disease Treatment Market Size by Application
7.3.1 Europe Alzheimer Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Alzheimer Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Alzheimer Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Alzheimer Disease Treatment Market Size by Country
7.4.1 Europe Alzheimer Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Alzheimer Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Alzheimer Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Alzheimer Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alzheimer Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alzheimer Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Alzheimer Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Alzheimer Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alzheimer Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alzheimer Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Alzheimer Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alzheimer Disease Treatment Market Size (2016-2027)
9.2 Latin America Alzheimer Disease Treatment Market Size by Type
9.2.1 Latin America Alzheimer Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Alzheimer Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Alzheimer Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Alzheimer Disease Treatment Market Size by Application
9.3.1 Latin America Alzheimer Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Alzheimer Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Alzheimer Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Alzheimer Disease Treatment Market Size by Country
9.4.1 Latin America Alzheimer Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Alzheimer Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Alzheimer Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Alzheimer Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alzheimer Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alzheimer Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Alzheimer Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Alzheimer Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alzheimer Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alzheimer Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Alzheimer Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Alzheimer Disease Treatment Introduction
11.1.4 Allergan Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Alzheimer Disease Treatment Introduction
11.2.4 Eisai Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Alzheimer Disease Treatment Introduction
11.3.4 Novartis Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Alzheimer Disease Treatment Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Alzheimer Disease Treatment Introduction
11.5.4 Amgen Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Alzheimer Disease Treatment Introduction
11.6.4 Pfizer Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 UCB
11.7.1 UCB Company Details
11.7.2 UCB Business Overview
11.7.3 UCB Alzheimer Disease Treatment Introduction
11.7.4 UCB Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.7.5 UCB Recent Development
11.8 H. Lundbeck
11.8.1 H. Lundbeck Company Details
11.8.2 H. Lundbeck Business Overview
11.8.3 H. Lundbeck Alzheimer Disease Treatment Introduction
11.8.4 H. Lundbeck Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.8.5 H. Lundbeck Recent Development
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Company Details
11.9.2 F. Hoffmann-La Roche Business Overview
11.9.3 F. Hoffmann-La Roche Alzheimer Disease Treatment Introduction
11.9.4 F. Hoffmann-La Roche Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.9.5 F. Hoffmann-La Roche Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Alzheimer Disease Treatment Introduction
11.10.4 Eli Lilly Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 Ono Pharmaceutical
11.11.1 Ono Pharmaceutical Company Details
11.11.2 Ono Pharmaceutical Business Overview
11.11.3 Ono Pharmaceutical Alzheimer Disease Treatment Introduction
11.11.4 Ono Pharmaceutical Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.11.5 Ono Pharmaceutical Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Alzheimer Disease Treatment Introduction
11.12.4 Johnson & Johnson Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Alzheimer Disease Treatment Introduction
11.13.4 Daiichi Sankyo Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Merz Pharma
11.14.1 Merz Pharma Company Details
11.14.2 Merz Pharma Business Overview
11.14.3 Merz Pharma Alzheimer Disease Treatment Introduction
11.14.4 Merz Pharma Revenue in Alzheimer Disease Treatment Business (2016-2021)
11.14.5 Merz Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Alzheimer Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoamine Oxidase
Table 3. Key Players of Pain Inhibitor (acetylcholinesterase)
Table 4. Key Players of Glutamate Inhibitor
Table 5. Global Alzheimer Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Alzheimer Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Alzheimer Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Alzheimer Disease Treatment Market Share by Regions (2016-2021)
Table 9. Global Alzheimer Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Alzheimer Disease Treatment Market Share by Regions (2022-2027)
Table 11. Alzheimer Disease Treatment Market Trends
Table 12. Alzheimer Disease Treatment Market Drivers
Table 13. Alzheimer Disease Treatment Market Challenges
Table 14. Alzheimer Disease Treatment Market Restraints
Table 15. Global Alzheimer Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Alzheimer Disease Treatment Market Share by Players (2016-2021)
Table 17. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer Disease Treatment as of 2020)
Table 18. Ranking of Global Top Alzheimer Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Alzheimer Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Alzheimer Disease Treatment Product Solution and Service
Table 22. Date of Enter into Alzheimer Disease Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Alzheimer Disease Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Alzheimer Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Alzheimer Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Alzheimer Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Alzheimer Disease Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Alzheimer Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Alzheimer Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Alzheimer Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Alzheimer Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Alzheimer Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Alzheimer Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Alzheimer Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Alzheimer Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Alzheimer Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Alzheimer Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Alzheimer Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Alzheimer Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Alzheimer Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Alzheimer Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Alzheimer Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Alzheimer Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Alzheimer Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Alzheimer Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Alzheimer Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Alzheimer Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Alzheimer Disease Treatment Product
Table 65. Allergan Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Eisai Company Details
Table 68. Eisai Business Overview
Table 69. Eisai Alzheimer Disease Treatment Product
Table 70. Eisai Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 71. Eisai Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Alzheimer Disease Treatment Product
Table 75. Novartis Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Teva Pharmaceutical Industries Company Details
Table 78. Teva Pharmaceutical Industries Business Overview
Table 79. Teva Pharmaceutical Industries Alzheimer Disease Treatment Product
Table 80. Teva Pharmaceutical Industries Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Industries Recent Development
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Alzheimer Disease Treatment Product
Table 85. Amgen Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 86. Amgen Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Alzheimer Disease Treatment Product
Table 90. Pfizer Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. UCB Company Details
Table 93. UCB Business Overview
Table 94. UCB Alzheimer Disease Treatment Product
Table 95. UCB Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 96. UCB Recent Development
Table 97. H. Lundbeck Company Details
Table 98. H. Lundbeck Business Overview
Table 99. H. Lundbeck Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 100. H. Lundbeck Recent Development
Table 101. F. Hoffmann-La Roche Company Details
Table 102. F. Hoffmann-La Roche Business Overview
Table 103. F. Hoffmann-La Roche Alzheimer Disease Treatment Product
Table 104. F. Hoffmann-La Roche Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 105. F. Hoffmann-La Roche Recent Development
Table 106. Eli Lilly Company Details
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Alzheimer Disease Treatment Product
Table 109. Eli Lilly Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Ono Pharmaceutical Company Details
Table 112. Ono Pharmaceutical Business Overview
Table 113. Ono Pharmaceutical Alzheimer Disease Treatment Product
Table 114. Ono Pharmaceutical Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 115. Ono Pharmaceutical Recent Development
Table 116. Johnson & Johnson Company Details
Table 117. Johnson & Johnson Business Overview
Table 118. Johnson & Johnson Alzheimer Disease Treatment Product
Table 119. Johnson & Johnson Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 120. Johnson & Johnson Recent Development
Table 121. Daiichi Sankyo Company Details
Table 122. Daiichi Sankyo Business Overview
Table 123. Daiichi Sankyo Alzheimer Disease Treatment Product
Table 124. Daiichi Sankyo Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 125. Daiichi Sankyo Recent Development
Table 126. Merz Pharma Company Details
Table 127. Merz Pharma Business Overview
Table 128. Merz Pharma Alzheimer Disease Treatment Product
Table 129. Merz Pharma Revenue in Alzheimer Disease Treatment Business (2016-2021) & (US$ Million)
Table 130. Merz Pharma Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Monoamine Oxidase Features
Figure 3. Pain Inhibitor (acetylcholinesterase) Features
Figure 4. Glutamate Inhibitor Features
Figure 5. Global Alzheimer Disease Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Sales Case Studies
Figure 9. Alzheimer Disease Treatment Report Years Considered
Figure 10. Global Alzheimer Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Alzheimer Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Alzheimer Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Alzheimer Disease Treatment Market Share by Regions (2022-2027)
Figure 14. Global Alzheimer Disease Treatment Market Share by Players in 2020
Figure 15. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer Disease Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer Disease Treatment Revenue in 2020
Figure 17. Global Alzheimer Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Alzheimer Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Alzheimer Disease Treatment Market Share by Type (2016-2027)
Figure 21. North America Alzheimer Disease Treatment Market Share by Application (2016-2027)
Figure 22. North America Alzheimer Disease Treatment Market Share by Country (2016-2027)
Figure 23. United States Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Alzheimer Disease Treatment Market Share by Type (2016-2027)
Figure 27. Europe Alzheimer Disease Treatment Market Share by Application (2016-2027)
Figure 28. Europe Alzheimer Disease Treatment Market Share by Country (2016-2027)
Figure 29. Germany Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Alzheimer Disease Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Alzheimer Disease Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Alzheimer Disease Treatment Market Share by Region (2016-2027)
Figure 39. China Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Alzheimer Disease Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Alzheimer Disease Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Alzheimer Disease Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Alzheimer Disease Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Alzheimer Disease Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Alzheimer Disease Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Alzheimer Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 59. Eisai Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 64. UCB Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 65. H. Lundbeck Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 68. Ono Pharmaceutical Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 70. Daiichi Sankyo Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 71. Merz Pharma Revenue Growth Rate in Alzheimer Disease Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の認知症＆アルツハイマー病治療市場規模・現状・予測（2021年-2027年） Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily lives of patients. Market Analysis and Insights: Global Dementia and Alzheimer’s Disease Treatment Mark…- アルツハイマー病治療薬のグローバル市場2021 Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage trea…
- 世界のパーキンソン病治療市場規模・現状・予測（2021年-2027年） Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors s…
- 世界のペイロニー病治療市場規模・現状・予測（2021年-2027年） Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. Market Analysis and Insights: Global Peyronie’s Disease Treatment Market The global Peyronie’s Disease Treatment market size is projected to reach US$ XX …
- 世界の神経変性疾患治療市場規模・現状・予測（2021年-2027年） Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s disease, Parkinson’s disease, ADHD, and ALS, can result in loss of memory and cognitive control. While cures for such conditions are very limited, over …